// App-Quantinova.ai

T5200 2016 AHA : The Impact of Smoking on Clinical Outcomes and the Role of Double-Dose versus Standard-Dose Clopidogrel Among Individuals With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention - Insights From the CURRENT-OASIS 7 Trial

Researchers

Presenter

  • Darar Al Khdair

Principal Investigators

  • David P Faxon

  • Kari Niemela

  • Peggy Gao

  • Keith A A Fox

  • Salim Yusuf

  • Shamir R Mehta

  • Christopher B Granger

  • Sanjit Jolly

  • Madhu Natarajan

  • Jean-Francois Tanguay

  • Gabriel Steg

  • Gilles Montalescot

  • Petr Widimsky

Medical Centers

  • Charles Univ in Prague and Univ Hosp Kralovske Vinohrady, Prague, Czech Republic

  • McMaster University, Hamilton, ON, Canada

  • Duke Medcl Ctr, Durham, NC

  • Kuwait Univ, Chest Diseases Hosp, Kuwait City, Kuwait

  • Univ de Montreal and Montreal Heart Inst, Montreal, QC, Canada

  • Tampere Univ Hosp, Tampere Univ, Tampere, Finland

  • Ctr Hospier Univire Pitie-Salpetriere AP-HP, Univ of Paris VI, Paris, France

  • Brigham and Womens Hospital/Harvard University, Boston, MA

  • UPMC Univ Paris 6, Paris, France

  • The University of Edinburgh, Edinburgh, United Kingdom

Locations

  • Finland

  • Czech Republic

  • Canada

  • United Kingdom

  • Kuwait

  • United States

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved